Title: Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists.
Journal: Bioorganic & medicinal chemistry letters 20080501
175135-32-7
2010-06-2
105512-80-9
21331-43-1
77815-14-6
52253-69-7
145307-34-2 | 1H-2-Benzopyran-5,6-diol, 1-(aminomethyl)-3,4-dihydro-3-tricyclo[3.3.1.13,7]dec-1-yl-, hydrochloride (1:1), (1R,3S)- | AA001KPD | MFCD03107804
14857-34-2 | Silane, ethoxydimethyl- | AA001KYR | MFCD00026750
149082-03-1 | 3,5-Dimethyl-2-hydroxymethyl-4-nitropyridine | AA001LAH | MFCD03426035
149427-58-7 | 4-(Trifluoromethyl)-1h-pyrrole-2-carboxylic acid | AA001LLZ | MFCD13190112
149739-51-5 | 3-(1H-Pyrazol-5-yl)benzonitrile | AA001LW3 | MFCD09860597
150010-20-1 | 2-Bromo-5-methylpyrimidine | AA001M5P | MFCD09753737
150319-83-8 | Methyl 3-aminophenylacetate, HCl | AA001MG3 | MFCD11501071
1508446-57-8 | 2-Cyanocyclobutane-1-carboxylic acid | AA001MTA | MFCD24024437
15118-60-2 | 4-(4-Aminophenyl)butyric acid | AA001N2Q | MFCD00075052
151417-38-8 | 1,3,5-Tris(4-iodophenyl)benzene | AA001N9D | MFCD07369795